|
Market Closed -
Nasdaq
16:00:00 2026-10-27 EDT
|
5-day change | 1st Jan Change | ||
| 4.160 USD | +1.96% |
|
+0.24% | +45.96% |
| 09-20 | Oramed Pharmaceuticals Inc.(NasdaqCM:ORMP) added to S&P Global BMI Index | CI |
| 08-31 | Lifeward Names Josh Hexter as Interim CEO and Rami Aviram as CFO | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +1.96% | +0.24% | -12.05% | 0.00% | +45.96% | +75.53% | +124.86% | -81.89% | -38.28% | 170M | |
| -3.10% | -4.19% | -12.88% | +13.49% | +56.09% | +32.67% | +59.47% | +4.36% | - | 65.28B | |
| +0.33% | +0.33% | -7.38% | -0.89% | +9.21% | +10.16% | +78.07% | +225.62% | +5,451.77% | 54.57B | |
| +0.16% | +1.73% | +11.70% | +13.66% | +18.22% | +9.89% | +102.10% | -15.79% | +259.62% | 53.59B | |
| -0.75% | +1.38% | +0.44% | +27.36% | +20.47% | +24.89% | +50.91% | +6.79% | +276.63% | 45.03B | |
| -1.30% | -4.80% | +1.44% | +12.32% | +20.49% | +16.05% | +114.76% | -0.33% | +1,015.68% | 42.17B | |
| +1.26% | -5.26% | -9.15% | -0.98% | +133.80% | +221.12% | +900.64% | +574.95% | - | 39.42B | |
| -0.74% | -4.46% | +6.31% | +5.54% | +9.41% | +11.00% | +44.65% | +4.75% | +151.07% | 32.71B | |
| -2.70% | -10.77% | -15.74% | +15.52% | +42.05% | +19.80% | -6.47% | -61.99% | - | 24.01B | |
| +1.11% | +15.18% | +31.62% | +57.08% | +47.85% | +60.27% | +49.33% | +3.20% | +162.43% | 26.5B | |
| +0.23% | -4.51% | -11.63% | -4.42% | -8.55% | -17.91% | -4.54% | -68.77% | - | 21.82B | |
| +1.75% | -0.74% | -19.41% | -9.33% | -45.44% | -42.10% | +297.65% | +259.70% | +590.12% | 20.38B | |
| -0.44% | +8.25% | +8.87% | +14.32% | +19.97% | +12.96% | +169.21% | +219.94% | +2,244.43% | 18.93B | |
| +0.44% | +13.75% | +22.54% | +59.98% | +79.89% | +83.76% | +107.91% | -16.56% | +369.19% | 17.06B | |
| -0.58% | +8.20% | +10.50% | +27.73% | +36.99% | +38.81% | +84.70% | -16.52% | +107.58% | 16.69B | |
| +0.37% | +1.49% | +12.36% | +17.09% | +49.10% | +63.42% | +223.51% | +206.81% | +498.44% | 16.13B | |
| +0.29% | +4.92% | +8.98% | -2.99% | - | - | - | - | - | 16.1B | |
| +2.59% | +3.03% | +3.03% | -0.42% | +180.86% | +161.39% | +341.90% | +1,405.54% | +779.81% | 14.75B | |
| -0.44% | +5.05% | +6.18% | +8.41% | +0.42% | +0.52% | -22.24% | -35.05% | +127.36% | 14.18B | |
| -5.62% | -3.16% | -2.96% | -11.74% | +15.55% | +5.49% | +488.95% | - | - | 14.63B | |
| Average | -0.26% | +3.91% | +1.64% | +12.09% | +38.54% | +41.46% | +168.70% | +145.26% | +856.85% | 27.71B | |
| Weighted average by Cap. | -0.51% | +2.92% | +0.50% | +12.60% | +36.67% | +38.55% | +161.32% | +123.06% | +1,233.38% |
- Stock Market
- Stocks
- ORMP Stock
- Sector Oramed Pharmaceuticals Inc.
Select your edition
All financial news and data tailored to specific country editions
